FindTrial
Sign In

Hypernatremia in Hydatid Cyst Treatment

Systematic Review of Hypernatremia Following Hydatid Cyst Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05090020
Enrollment
30
Registered
2021-10-22
Start date
2021-02-01
Completion date
2021-10-31
Last updated
2021-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Echinococcosis, Hepatic

Keywords

Echinococcosis, Hepatic, hypernatremia

Brief summary

Hypertonic saline (HS) is one of the most widely used scolocidal agents in the treatment of hydatid cysts. Hypernatremia is one of the complications associated with the use of HS. It can cause hypernatremia, acid-base disorder, impaired lung, renal, cardiac and neurological functions and even death. Therefore, caution should be exercised in the use of HS, and open technique should be preferred in surgery.

Interventions

PROCEDURETreatment

Surgery and PAIR

Sponsors

Trabzon Kanuni Education and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Patients who developed hypernatremia (plasma sodium value above 145 mmol/L) due to HS use in the treatment of hydatid cyst were included to study -

Exclusion criteria

Patients who developed hypernatremia due to other treatments were excluded from the study. \-

Design outcomes

Primary

MeasureTime frameDescription
Prevention of hypernatreima3 monthHypernatremia is plasma sodium value above 145 mmol/L.

Countries

Turkey (Türkiye)

Contacts

Primary ContactAydıin Aktas
aydinaktas2004@gmail.com+905308807983
Backup ContactCuneyt Kayaalp
cuneytkayaalp@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026